Offshore
Photo
Wall St Engine
Trump: THE CONSENSUS OF ALMOST EVERYBODY IS THAT, “THE FED SHOULD CUT RATES SOONER, RATHER THAN LATER.” Too Late Powell, a man legendary for being Too Late, will probably blow it again - But who knows??? https://t.co/qfKWtoINQK
tweet
Trump: THE CONSENSUS OF ALMOST EVERYBODY IS THAT, “THE FED SHOULD CUT RATES SOONER, RATHER THAN LATER.” Too Late Powell, a man legendary for being Too Late, will probably blow it again - But who knows??? https://t.co/qfKWtoINQK
tweet
Offshore
Video
The All-In Podcast
Friedberg: Two Reasons Why Drug Prices are So Expensive in America 📈 🫰
1) Government intervention in the market 🏢
"The way that we negotiate drug prices is pretty messed up."
"As is the case with the cost of education and the cost of housing, the cost of drugs is largely inflated because of the federal government's role in being the primary buyer or capital provider to that market."
"Through our purchases of prescription drugs, the federal government, as a buyer, doesn't have any incentive to keep prices low."
" If every individual had to pay for their drugs, or private insurance was the only way to get your drugs, we would have a much more dynamic marketplace."
2) PBMs marking up prices 📈
"There's also this construct in the market, these PBMs or pharmacy benefit managers."
"If they got cut out of the market, it would save a lot."
"There's three major PBMs, CVS Caremark, Express Scripts, and Optum RX. They make money in markups."
"The FTC has been investigating them and have several open cases."
"Between 2017 and 2022, the estimate is that these companies generated $7.3B in excess profit by marking up prices on specialty generic drugs."
"So as an intermediary, they provide this role where they can coordinate between the health insurer, the pharmacy which dispenses the drugs, and the drug manufacturers."
Chamath:
" But they're allowed to be owned by the payer, which is crazy."
Friedberg:
" And now they're allowed to be owned by the payer."
"And there's a lot of obfuscation of the true cost of the drugs. There's a lot of markups, a lot of spread taking."
"And so if you took the PBMs out of the market, that would solve one of the problems."
" But at the end of the day, anytime the federal government is involved as a payer in any market-based system, it creates a distortion and the market is no longer free or efficient."
@friedberg
tweet
Friedberg: Two Reasons Why Drug Prices are So Expensive in America 📈 🫰
1) Government intervention in the market 🏢
"The way that we negotiate drug prices is pretty messed up."
"As is the case with the cost of education and the cost of housing, the cost of drugs is largely inflated because of the federal government's role in being the primary buyer or capital provider to that market."
"Through our purchases of prescription drugs, the federal government, as a buyer, doesn't have any incentive to keep prices low."
" If every individual had to pay for their drugs, or private insurance was the only way to get your drugs, we would have a much more dynamic marketplace."
2) PBMs marking up prices 📈
"There's also this construct in the market, these PBMs or pharmacy benefit managers."
"If they got cut out of the market, it would save a lot."
"There's three major PBMs, CVS Caremark, Express Scripts, and Optum RX. They make money in markups."
"The FTC has been investigating them and have several open cases."
"Between 2017 and 2022, the estimate is that these companies generated $7.3B in excess profit by marking up prices on specialty generic drugs."
"So as an intermediary, they provide this role where they can coordinate between the health insurer, the pharmacy which dispenses the drugs, and the drug manufacturers."
Chamath:
" But they're allowed to be owned by the payer, which is crazy."
Friedberg:
" And now they're allowed to be owned by the payer."
"And there's a lot of obfuscation of the true cost of the drugs. There's a lot of markups, a lot of spread taking."
"And so if you took the PBMs out of the market, that would solve one of the problems."
" But at the end of the day, anytime the federal government is involved as a payer in any market-based system, it creates a distortion and the market is no longer free or efficient."
@friedberg
tweet
Offshore
Video
Wall St Engine
RT @wallstengine: If you’ve been enjoying my free posts here on X, you’ll definitely want to check out my free weekly newsletter that I send every Sunday Morning.
Subscribe here (takes< 5 seconds):
https://t.co/hxa0gzPc0K https://t.co/QJR59ZLuVj
tweet
RT @wallstengine: If you’ve been enjoying my free posts here on X, you’ll definitely want to check out my free weekly newsletter that I send every Sunday Morning.
Subscribe here (takes< 5 seconds):
https://t.co/hxa0gzPc0K https://t.co/QJR59ZLuVj
tweet
Offshore
Photo
Dimitry Nakhla | Babylon Capital®
RT @DimitryNakhla: Yes, Burry sold all his stocks & purchased $EL
Yes, he purchased a ton of puts $NVDA $BABA $PDD $JD $EL $TCOM
This is not as “breaking news” as many make it seem
These filings snapshot past months
Burry likely cashed in on the April correction, closed shorts & flipped long Q2 https://t.co/EkDQ6GYNhS
tweet
RT @DimitryNakhla: Yes, Burry sold all his stocks & purchased $EL
Yes, he purchased a ton of puts $NVDA $BABA $PDD $JD $EL $TCOM
This is not as “breaking news” as many make it seem
These filings snapshot past months
Burry likely cashed in on the April correction, closed shorts & flipped long Q2 https://t.co/EkDQ6GYNhS
tweet
Offshore
Photo
Investing visuals
$USLM: outperforming stocks like $HIMS, $TSLA and $HOOD over the past 5 years.
A short thread 👇🧵 https://t.co/r3d45PoHR7
tweet
$USLM: outperforming stocks like $HIMS, $TSLA and $HOOD over the past 5 years.
A short thread 👇🧵 https://t.co/r3d45PoHR7
tweet
Wall St Engine
FDA APPROVES $NVAX COVID VACCINE—WITH RESTRICTIONS
The U.S. has approved Novavax’s COVID shot, but limited it to adults 65+ and those 12–64 with at least one underlying condition. The FDA didn’t define what qualifies as an underlying condition. Pediatric studies are still pending.
tweet
FDA APPROVES $NVAX COVID VACCINE—WITH RESTRICTIONS
The U.S. has approved Novavax’s COVID shot, but limited it to adults 65+ and those 12–64 with at least one underlying condition. The FDA didn’t define what qualifies as an underlying condition. Pediatric studies are still pending.
tweet
Offshore
Photo
Investing visuals
You're given $100,000. Would you invest it in $TSLA or $BYD? https://t.co/TxiDrT1KJZ
tweet
You're given $100,000. Would you invest it in $TSLA or $BYD? https://t.co/TxiDrT1KJZ
tweet